Association between oral lichen planus and systemic conditions and medications: Case-control study
- PMID: 32750751
- DOI: 10.1111/odi.13572
Association between oral lichen planus and systemic conditions and medications: Case-control study
Abstract
Objective: The aim of this study is to investigate the association between oral lichen planus (OLP) and a variety of systemic conditions, medication, and supplement usage.
Materials and method: A total of 156 patients diagnosed with OLP and 156 controls at Columbia University Irving Medical Center from 2000 to 2013 were selected as part of the matched (1:1) case-control study. Demographics, systemic conditions, prescription medications and supplements were extracted from the patients' medical records. A univariable conditional logistic regression (CLR) analysis was performed to calculate unadjusted odds ratio, to identify significant variables associated with OLP (p < .10). Significant variables were further tested using multivariable CLR analysis with both forward and backward selection to calculate adjusted odds ratio (aOR) and further distinguish variables associated with OLP (p < .05).
Results: This analysis identified six significant variables: thyroid disorder (aOR:5.1,95%CI:2.3-11.2), any form of cancer (aOR:3.4,95%CI:1.4-8.4), type 2 diabetes (aOR:2.8,95%CI:1.2-6.3), hyperlipidemia (aOR:2.3,95%CI:1.3-4.1), oral sedative usage (aOR:6.3,95%CI:1.8-22.5), and vitamin D supplementation (aOR:2.7,95%Cl:1.3-6.0).
Conclusion: Thyroid disorders, cancer, type 2 diabetes, hyperlipidemia, sedatives, and vitamin D supplementation were found to be associated with OLP. Additional investigation is required to explore these associations, which could shed light on the potential mechanism of OLP and reinforce the idea that oral lesions could be predicative of previously undetected systemic conditions.
Keywords: cancer; medications; oral lichen planus; systemic diseases; thyroid disorders.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.
Comment in
-
Clinical investigation on oral lichen planus and associated comorbidities needs a holistic concept.Oral Dis. 2023 Jan;29(1):327-329. doi: 10.1111/odi.14181. Epub 2022 Mar 13. Oral Dis. 2023. PMID: 35253328 No abstract available.
References
REFERENCES
-
- Adamo, D., Ruoppo, E., Leuci, S., Aria, M., Amato, M., & Mignogna, M. D. (2015). Sleep disturbances, anxiety and depression in patients with oral lichen planus: A case-control study. Journal of the European Academy of Dermatology and Venereology, 29(2), 291-297. https://doi.org/10.1111/jdv.12525
-
- Alqahtani, M., Woods, T. R., Smith, M. H., Battacharyya, I., Cohen, D. M., Islam, M. N., & Fitzpatrick, S. G. (2018). Medication use and medical history of 155 patients with oral lichenoid lesions: A retrospective study. Gen Dent., 66(2), 40-45.
-
- Alrashdan, S. M., Cirillo, N., & McCullough, M. (2016). Oral lichen planus: A literature review and update. Archives of Dermatological Research, 308, 539-555. https://doi.org/10.1007/s00403-016-1667-2
-
- Aranow, C. (2011). Vitamin D and the immune system. Journal of Investigative Medicine, 59(6), 881-886. https://doi.org/10.2310/JIM.0b013e31821b8755
-
- Arduino, P. G., Karimi, D., Tirone, F., Sciannameo, V., Ricceri, F., Cabras, M., … Broccoletti, R. (2017). Evidence of earlier thyroid dysfunction in newly diagnosed oral lichen planus patients: A hint for endocrinologists. Endocrine Connections, 6(8), 726-730. https://doi.org/10.1530/EC-17-0262
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
